B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases

Fukuoka igaku zasshi = Hukuoka acta medica

Volumn 96, Issue 4, 2005, Pages 86-92

  Kondo, Shiori ^a   Akashi, Tomoyuki ^a   Katsuta, Hitoshi ^a   Iwakiri, Ryuichi ^a   Anzai, Keizo ^a   Nagafuchi, Seiho ^a   Niho, Yoshiyuki ^a   Harada, Mine ^a  

^a MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; MONOCLONAL ANTIBODY; RITUXIMAB;

ANIMAL; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; METHODOLOGY; MOUSE; NONOBESE DIABETIC MOUSE; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD20; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOTHERAPY; MICE; MICE, INBRED NOD; T-LYMPHOCYTES;

EID: 23844517518     PISSN: 0016254X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)